With COVID-19, the Global South Again Bears the Crisis Burden
I woke up Sunday morning to music, an instrumental ballad gently beckoning the day accompanied by the squeals of my excited pets. Cue the morning soundtrack: water running, keys jangling, sandals on pavement, the machinations of a coffee shop, the crunch of a croissant on a busy DC street, the crinkling of newspapers. And then silence. I’ve just been hurled out of my bubble by a headline: the New York Times reports India has again broken the world record with a reported 400,000 cases. There are no sounds now, just feelings. The tightness in my chest, the increasing pit in my stomach, the dizziness from inadvertently holding my breath. It’s never far from my thoughts, this constant reckoning of my sheer, dumb luck to be who I am, where I am.
We talk a lot about privilege. We talk about gender, education, sexual orientation, all of it. But the most visceral privilege for me has always been a factor before any of those could be supposed: I was born into a family capable of traveling the world and choosing the country to live in, away from the jenga tower of everyday traumas that would surely have been our lives had we been rendered immobile. This fact is never far from my thoughts but now it glared at me, in somber black print.
For South Asians in the United States, and Indians in particular, this is the soul-crushing reckoning happening in real-time. Most of us have been vaccinated, or have access to be, comforted by the sense we are moving farther away from the darkest days of the damage this pandemic. I am overwhelmed with gratitude for the systems and science that has afforded me some peace of mind but it is a short-lived peace, isn’t it, watching the grandmotherland go up in flames?
There are no words to fill this silence. What the quiet captures is the sense of those carefully curated atoms of our identity falling apart, the portal that was always there showing you what your life could so easily have been passing through you, leaving you with a more perceptive eye, a tuned ear and painful realizations.
I knew last summer South and Central Asia were not prepared. How could they possibly be, when the West was not? The world’s most densely populated region could not point to food or housing security, modern hospitals, general access to clean running water, news and information. In multi-generational houses, social distancing was a pipe dream and images of slums outside New Delhi, Karachi and countless other cities were the dream venues for new coronavirus strains. I knew better than to trust national estimates of new cases and death tolls. I knew it would be uglier than we would ever know. I can promise you the unknowable actual number is multiples higher than 400,000.
Compounding the grief is the cold response to India by the same systems that have sustained us. Wealthy countries have inoculated millions of their citizens but the vaccine inequities across the Global South are agonizing to witness. The term is a relatively new one, used to identify lower-income countries and was pitched as an alternative to the “Third World” and “developing countries” terms. It is not geographically applied; for example, most of the global south is South America but the term refers to countries working to industrialize and which have suffered a history of colonialism and/or imperialism by what we call the developed West. Consider the very developed countries are what they are at the expense of the impoverishment of most of humanity today.
It just does not have to be this way. There is a duty to respond enshrined in global treaties for a reason. When it comes to the crisis at hand, it’s clear the United States and Europe have unreasonably limited vaccine production to a handful of companies struggling to meet the overwhelming demand while in Asia, Africa and Latin America factories are desperate for the work. It is hard to remain grateful for systems that bank every decision on power and not in critical moments, on global health. Russia has shared the blueprint for its Sputnik vaccine production with Brazil, India, Turkey and South Korea and that goodwill will certainly not be forgotten. The U.S. and Europe have far more to gain by sharing technologies and dismantling monopolies if we are ever to get out of a cycle of variants and wretched images of human suffering. Governments will need to recognize the benefits of patent-sharing and tap into the brilliance of scientists and manufacturers across the world. We need to bet on investing in people and we have the funding to make it happen.
In the first couple of years of my policy career, I found myself forced to view the South Asia region through a narrow definition of national security. It almost brought me to tears to see Pakistan offering its rival India all the help it could provide in this stark moment. Nuclear capabilities, terrorism and all-things-Afghanistan rule the political airwaves, but it must be incredibly hard to care about any of that when COVID-19 becomes the great equalizer.
We have asked the Global South to bear the brunt of nearly every crisis, from climate change to public health, but this is a chance to make some right calls. Opening the vaccine technology will bring this pandemic and images of pyres burning to an end and can potentially be the first meaningful step to addressing long standing geopolitical inequities driving this crisis. Those lives matter just as much as yours or mine.
All these thoughts crash into each other in the few minutes of a deeply uncomfortable silence. The hope is to emerge on the other side of the silence with an identity more bold, more generous, turning a fleeting moment into something a little more eternal. But words alone won’t cut it. Every conversation leading to significant change in just the last two years has been powered by a compelled and impassioned public. A Democratic administration keen on rebuilding American leadership across the globe should be held to a collaborative, people-over-profit standard and address the glaring inequity.
On a more personal note, if you can spare a moment to turn the tide back, here is a great list of resources doing critical work on the ground in India.
Thanks for writing this. I am actually from the Caribbean and have watched in bewilderment as the US sits on vaccines it probably will not use (Rasta-Zeneca as they call it in Jamaica) while countries they could easily help are appealing for shots to give their populations. This is even more bizarre, because the Caribbean is where Americans go to vacation; these are places right in the backyard of the US; these are small populations that rely almost entirely on tourism.
When it comes to larger countries – India particularly tragic because it is crucial to the rollout of vaccines for most of the planet – it is pretty depressing watching countries report having 4 or 5 times the vaccines they need (according to the Washington Post the US will have an oversupply of some 300 million vaccine doses by July). plus ça change…Report
Reading this, I have the Copenhagen Interpretation of Ethics scratching at the back of my head again.
The essay’s precis shows up in the 2nd paragraph: “The Copenhagen Interpretation of Ethics says that when you observe or interact with a problem in any way, you can be blamed for it. At the very least, you are to blame for not doing more. Even if you don’t make the problem worse, even if you make it slightly better, the ethical burden of the problem falls on you as soon as you observe it. In particular, if you interact with a problem and benefit from it, you are a complete monster.”
For the record, I think that the US should be exporting a heck of a lot more vaccines than it is. I think that the J&J pause (for CAMAB persons, anyway) was morally outrageous. The fact that we were sitting on millions of AZ shots and just not doing anything with them? That choice only makes sense in a world where the incentives line up so that you get ignored for 5,000,000 people dying from the disease and punished for 100 people dying from the shot.
I think that the US should be doing more to get more doses into more arms into the 3rd World. It’s incredibly disappointing that we have millions of doses that we’re just sitting on.
But I am very glad that we have millions of doses in the first place. I’d like there to be tens and tens and tens of millions of doses in less than a year the next time something awful happens.Report
It sounds like we could share the tech without any detriment to the US. If so, we should do so.
The US has lost twice as many people as India, and until it becomes clear that the next dose of vaccine produced won’t improve the situation in the US, I can understand not sharing any vaccine.Report
…until it becomes clear that the next dose of vaccine produced won’t improve the situation in the US, I can understand not sharing any vaccine.
SWAG: three weeks. By the first week of June, a significant amount of the vaccine being produced for US delivery will expire before it goes in US arms.Report
Seems to me like it’s just a matter of number crunching. We should still prioritize ourselves at the plateau rate. Resell or donate the excess. Where expiration is a concern send them to Mexico or the Caribbean so they have the best chance of being used before time runs out.Report
As a South African, I get that the Global North (if I can use that term in contrast to the Global South) has paid for the development of these medical miracles and has thus earned the right of first access to them. I get that charity starts at home. More fundamentally, the Global North have created societies where the development of these miracles is possible. Us Africans and Indians and South Americans have messed up our societies so we can’t develop vaccines ourselves, so that’s on us.
But that holds only up to a point. Canada has now authorised the Pfizer shots for 12-16 year olds. Seriously? To keep these life-saving medications for people at extremely low risk of harm, while the rest of us are desperate to even get our front-line health workers vaccinated?
It’s like, imagine a bunch of rich kids decide to use their money to set up a kiosk at school selling food. Ok, they did the hard work and bought the stock so if at first they stand in front of the queue to buy it’s understandable. But after a while the rich kids aren’t really hungry any more, now they’re just stuffing themselves. But they are still not allowing the hungry poor kids to buy food.
And please note; we do not ask for handouts. We will pay with dollars as good any other.Report
Yeah, now that Canada has an incredible 3% of our population fully vaccinated, we’re sitting pretty lemme tell you. Just about to herd immunity.Report
The US Ambassador Katherine Tai has called for the release of IP protection.
Report
Looking at a bunch of literature with my old instant-expert systems guy hat on, here’s the problem. The secret sauce for the mRNA vaccines, the most important piece of the product, is the materials and methods for encapsulating the mRNA in lipid nanoparticles (LNPs). There are any number of university or commercial medical labs in the world that can crank out the mRNA in job lots. There are (almost) literally a handful who can wrap it in LNPs. And not many more who can produce the precursor chemicals for those LNPs. The weird supply chains look like they do for reasons related to that. Having licked the problem, protected as trade secrets not patents, Pfizer and Moderna are getting ready to crank out all sorts of experimental vaccines: better flu, HIV, maybe the common cold.
I’m glad it’s not my decision. It is one thing for the administration to say, “Show the world how to do the LNP thing.” It’s another to say, “Trust us that we will go to the wall in the future to punish anyone, anywhere in the world, who uses it to wrap anything except Covid-19 mRNA.”Report
I admit that my assumption was that they were doing something that was reverse-engineerable by sufficiently smart and funded individuals… tied to the whole “we had only recently started testing this stuff on mice” thing.Report
They are. You just left out an important qualifier on “sufficiently smart and funded”: in a timely fashion. Process stuff is always hard. These lipids, solvents, and other reagents, introduced in the proper portions, in the proper order, under the proper conditions, filtered in various ways to yield what is necessary for the next step… As opposed to going to Moderna or Pfizer and saying, “If we give you another $20B up front, how fast can you produce a billion doses for India? For Africa? $40B?” My intuition is that Moderna and Pfizer can produce all the vaccine the world needs faster than they can teach (and equip) the Global South to do it.
The OP raises an interesting open-ended question about teaching the Global South to produce their own vaccines the next time. I would add to that “keeping them ready if the next time is 20 years away.”Report
Pfizer and Moderna came up with (more or less) the same thing, though, right?
I thought that the main difference between the two shots was how much of a payload of the active ingredient they delivered (the google says 30micrograms vs. 100micrograms). But, like, they’re both doing the mRNA thing.
Which means that it’s independently findable with sufficient funding.
Which tells me that if this process was released to the Global South, the problem would be in making a factory that could make it. Or make the four factories required to make it, as well as a fifth factory to make sterile syringes that could handle being jostled by being driven on a potholey road.
I mean, I get the feeling that Moderna could release the trade secrets *TODAY*.
And we still wouldn’t have anybody but Pfizer and Moderna making mRNA vaccines in 2031.
Is that off-base?Report
I mean, I get the feeling that Moderna could release the trade secrets *TODAY*…. And we still wouldn’t have anybody but Pfizer and Moderna making mRNA vaccines in 2031. Is that off-base?
China certainly would, as a matter of prestige, like their space station. Japan, Taiwan, and South Korea are paranoid enough about SARS and other nasty respiratory viruses that they probably would. India if they they think they can make a buck at it. Israel is almost certainly capable, and supplying Africa with vaccines for Marburg, Ebola, etc would seem like a good foreign policy decision for them.Report
I just encountered this and it confirms my priors.
Report
” It’s another to say, “Trust us that we will go to the wall in the future to punish anyone, anywhere in the world, who uses it to wrap anything except Covid-19 mRNA.” ”
You’re assuming that the people calling for rescinding of IP protection on the COVID-19 vaccine think that anything involving healthcare should have any protection. Reconsider that assumption.Report
I admit that I’m taking, “The Administration believes strongly in intellectual property protections…” at face value. The question of where in the world IP regarding health care innovation might be safe is a discussion for a different time.Report
I keep hearing the US is well on our way to having a billion doses. Is that 1B cumulative (administered plus on hand) or 1B on hand? Either way, my back of the envelope math tells me that’s more than we need. Like way more. And, yes, maybe we will need a booster at some point but… if we can get to 1B in 6 months we could get to like, 2B in 12 months, right?Report